BRIEF-Epsium Enterprise Limited Says Now Sees U.S.IPO Of Up To 1.25 Million Ordinary Shares - SEC Filing-February 2024-www.financetom.com

BRIEF-Epsium Enterprise Limited Says Now Sees U.S.IPO Of Up To 1.25 Million Ordinary Shares - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Epsium Enterprise Limited Says Now Sees U.S.IPO Of Up To 1.25 Million Ordinary Shares - SEC Filing

Feb 3, 2025 12:19 PM

Feb 3 (Reuters) - Epsium Enterprise Limited:

* EPSIUM ENTERPRISE LIMITED: NOW SEES U.S. IPO OF UP TO 1.25

MILLION ORDINARY SHARES - SEC FILING

* EPSIUM ENTERPRISE LTD: EXPECT U.S. IPO PRICE WILL BE

BETWEEN

$4.00 AND $5.00 PER ORDINARY SHARE

Source text:

;))

Previous page： Structure Therapeutics Names Chief Medical Officer, Chief Development Officer Next page： BRIEF-Maine Public Utilities Commission Approves Avangrid's Request For Merger Exemption

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Structure Therapeutics Names Chief Medical Officer, Chief Development Officer

Sep 18, 2024

04:23 PM EDT, 09/17/2024 (MT Newswires) -- Structure Therapeutics ( GPCR ) said late Tuesday it has promoted Blai Coll to chief medical officer, replacing Mark Bach as part of a planned succession, effective Sept. 18. Coll has been vice president of clinical development at Structure since 2022, the company said. Additionally, Ashley Hall has been appointed to the newly...

BRIEF-Maine Public Utilities Commission Approves Avangrid's Request For Merger Exemption

Sep 18, 2024

Sept 17 (Reuters) - Avangrid Inc ( AGR ): * MAINE PUBLIC UTILITIES COMMISSION APPROVES AVANGRID'S REQUEST FOR MERGER EXEMPTION * AVANGRID INC ( AGR ) - MAINE PUC GRANTS EXEMPTION FOR IBERDROLA'S ACQUISITION OF 18.4% OF AVANGRID * AVANGRID INC ( AGR ) - TRANSACTION EXPECTED TO CLOSE IN Q4 2024 PENDING NYPSC AND SHAREHOLDER APPROVAL * AVANGRID INC...

Qualys Insider Sold Shares Worth $882,552, According to a Recent SEC Filing

Sep 18, 2024

04:24 PM EDT, 09/17/2024 (MT Newswires) -- Sumedh S Thakar, Director, CEO & President, on September 16, 2024, sold 7,000 shares in Qualys ( QLYS ) for $882,552. Following the Form 4 filing with the SEC, Thakar has control over a total of 179,649 shares of the company, with 179,649 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1107843/000141588924023516/xslF345X05/form4-09172024_080916.xml ...

Cytokinetics Insider Sold Shares Worth $414,401, According to a Recent SEC Filing

Sep 18, 2024

04:23 PM EDT, 09/17/2024 (MT Newswires) -- Fady Ibraham Malik, Executive Vice President, Research & Development, on September 17, 2024, sold 7,300 shares in Cytokinetics ( CYTK ) for $414,401. Following the Form 4 filing with the SEC, Malik has control over a total of 120,920 shares of the company, with 120,920 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1061983/000112760224024083/xslF345X05/form4.xml ...